BLIRT S.A. (3SL.F)

2.7600 0.0000 (0.00%) As of 09:16AM CEST. Market open.

BLIRT S.A.

Trzy Lipy 3/1.38
Gdansk 80-172
Poland
48 58 739 6150
https://www.blirt.eu

Sector(s): 
Industry: 
Full-time employees: 70

Key executives

Name	Title	Pay	Exercised	Year born
Thierry Bernard	Chief Executive Officer	N/A	N/A	N/A
Mr. Krzysztof Kur Ph.D.	Member of the Managing Board & R&D	N/A	N/A	N/A
Mr. Tomasz Wrzesinski	Member of the Managing Board	N/A	N/A	N/A
Katarzyna Spirin-Polak	Member of the Managing Board	N/A	N/A	N/A
Roland Sackers	Member of the Managing Board	N/A	N/A	N/A
Ms. Aleksandra Kukiello	Chief Business Support Officer	N/A	N/A	N/A
Mr. Piotr Wierzbicki	Secretary & Member of the Supervisory Board	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

BLIRT S.A. engages in the manufacture and sale of recombinant enzymes for the life science industry. It offers proteins and enzymes, such as proteinases, RNase inhibitors, polymerases, nucleases, ligases, and other proteins; and molecular biology reagents, including DNA and RNA extraction, PCR and real-time PCR, reverse transcriptions, and RNA related products. BLIRT S.A. was founded in 1994 and is headquartered in Gdansk, Poland. BLIRT S.A. operates as a subsidiary of Qiagen N.V.

Corporate governance

BLIRT S.A.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.